Logo

Dutch Firm DSM Licenses Genomatica s Modeling Platform; Firms to Develop Model for Production Organism

Apr 19, 2005

NEW YORK, April 19 (GenomeWeb News) - Genomatica has signed a software licensing and development deal with DSM, a Dutch chemical and biotechnology firm, the company said today.

 

Under the agreement, DSM will license SimPheny, Genomatica's modeling and simulation platform, to use for strain engineering, process development, and other research areas. In addition, the two companies will jointly develop a metabolic model of production organism for SimpPheny.

 

San Diego-based Genomatica will receive undisclosed licensing fees and milestone payments.

Breaking News
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.